Literature DB >> 1296998

Use of lithium in maintaining T-cell functions in persons with documented acquired immunodeficiency syndrome.

W C Jordan1.   

Abstract

This article presents two patients with human immunodeficiency virus who were treated with lithium and describes the possible effect the lithium may have had on their T-cell systems.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1296998      PMCID： PMC2571668     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


  3 in total

1.  Serological characterization of HTLV-III infection in AIDS and related disorders.

Authors:  J E Groopman; F W Chen; J A Hope; J M Andrews; R L Swift; C V Benton; J L Sullivan; P A Volberding; D P Sites; S Landesman
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

2.  Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods.

Authors:  D T Imagawa; M H Lee; S M Wolinsky; K Sano; F Morales; S Kwok; J J Sninsky; P G Nishanian; J Giorgi; J L Fahey
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

Review 3.  Activation and regulation of human immune responses: implications in normal and disease states.

Authors:  A S Fauci; H C Lane; D J Volkman
Journal:  Ann Intern Med       Date:  1983-07       Impact factor: 25.391
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.